{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.1/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Sildenafil",
            "Path": "../../Sildenafil-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [],
        "GOFMergedPlots": [],
        "ComparisonTimeProfilePlots": [
            {
                "SectionId": 1,
                "Title": "Hedaya 2006, Clarithromycin-Sildenafil",
                "SimulationDuration": 24,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Hedaya_Clari_control",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Hedaya 2006 - Clarythromycin DDI, control group - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Clarithromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Hedaya_Clari_treatment",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Hedaya 2006 - Clarithromycin DDI, treatment group - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                        "StartTime": 2,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment with Clarithromycin",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionId": 1,
                "Title": "Hesse 2005, Fluvoxamine-Sildenafil",
                "SimulationDuration": 24,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Hesse_Fluvo_control",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Hesse 2005 - Fluvoxamine DDI, control group - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Fluvoxamine)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Hesse_Fluvo_treatment",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Hesse 2005 - Fluvoxamine DDI, treatment group - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                        "StartTime": 240,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment with Fluvoxamine",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionId": 1,
                "Title": "Lee 2021, Clarithromycin-Sildenafil",
                "SimulationDuration": 24,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Lee_Clari_control",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Lee 2021 - Clarithromycin DDI, control group - Sildenafil - PO - 25 mg - Plasma - agg. (n=15)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Clarithromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Lee_Clari_treatment",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Lee 2021 - Clarithromycin DDI, treatment group - Sildenafil - PO - 25 mg - Plasma - agg. (n=15)",
                        "StartTime": 96,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment with Clarithromycin",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionId": 1,
                "Title": "Lee 2021, Itraconazole-Sildenafil",
                "SimulationDuration": 24,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Lee_Itra_control",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Lee 2021 - Itraconazole DDI, control group - Sildenafil - PO - 25 mg - Plasma - agg. (n=16)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Itraconazole)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Lee_Itra_treatment",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Lee 2021 - Itraconazole DDI, treatment group - Sildenafil - PO - 25 mg - Plasma - agg. (n=16)",
                        "StartTime": 96,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment with Itraconazole",
                        "Symbol": "Square"
                    }
                ]
            },
            {
                "SectionId": 1,
                "Title": "Muirhead 2002, Erythromycin-Sildenafil",
                "SimulationDuration": 24,
                "TimeUnit": "h",
                "OutputMappings": [
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Muirhead_Ery_control",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Muirhead 2002a - Erythromycin DDI, control group, D1 - Sildenafil - PO - 100 mg - Plasma - agg. (n=13)",
                        "StartTime": 0,
                        "TimeUnit": "h",
                        "Color": "#2166ac",
                        "Caption": "Control (without Erythromycin)",
                        "Symbol": "Circle"
                    },
                    {
                        "Project": "Sildenafil",
                        "Simulation": "DDI_Muirhead_Ery_treatment",
                        "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                        "ObservedData": "Muirhead 2002a - Erythromycin DDI, treatment group, D6 - Sildenafil - PO - 100 mg - Plasma - agg. (n=13)",
                        "StartTime": 121,
                        "TimeUnit": "h",
                        "Color": "#b2182b",
                        "Caption": "Treatment with Erythromycin",
                        "Symbol": "Square"
                    }
                ]
            }
        ],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [],
    "Sections": [
        {
            "Id": 1,
            "Title": "Plots",
            "Content": "Content/empty.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}